Middleton, WI, United States of America

Qufei Li

This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Exelixis, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qufei Li. Retrieved from https://idiyas.com/inventor/qufei-li-3anyaa75

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qufei Li: Innovator in Anti-ROR Antibody Constructs

Introduction

Qufei Li is a notable inventor based in Middleton, WI (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody constructs.

Latest Patents

Qufei Li holds a patent for "Anti-ROR antibody constructs." This patent includes pharmaceutical compositions comprising the constructs and methods of use thereof. He has 1 patent to his name, showcasing his innovative work in this area.

Career Highlights

Li is currently employed at Exelixis, Inc., a company known for its focus on developing innovative cancer therapies. His work at Exelixis has allowed him to contribute to advancements in medical science.

Collaborations

Some of his coworkers include Lucas Bailey and Malgorzata Agnieszka Nocula-Lugowska, who collaborate with him on various projects within the company.

Conclusion

Qufei Li's contributions to the field of biotechnology, particularly through his patent on Anti-ROR antibody constructs, highlight his role as an innovator in medical science. His work continues to impact the development of pharmaceutical compositions and methods of use.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…